Zurueck zur Suche

Reporte zur Charge FB-ER8735

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MA 4

VAERS 2126997

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FB-ER8735

moderat
Staat
MA
Alter
40,0
Geschlecht
F
Eingang
19.02.2022
Impfdatum
26.04.2021
Beginn
26.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain lower Asthenia Chills Dizziness Feeling abnormal Muscular weakness Pain in extremity Paraesthesia Sciatica Somnolence

Symptomtext

Left hand continues to hurt; Sciatica pain in her left leg flared up; Sharp pain at the bottom of her tummy; lingering tummy ache; General weakness; Brain fog; Dizziness; Chills; Slept most of the day; Left hand started to feel weak; Slight pins-and-needles feeling; This is a spontaneous report received from a contactable consumer. The reporter is the patient. A 40-year-old female patient received BNT162B2 (BNT162B2), administered in arm left, administration date 26Apr2021 15:45 (Lot number: FB-ER8735) at the age of 40 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Hand weakness" (unspecified if ongoing); "Pinched nerves in her spine" (unspecified if ongoing). Concomitant medication(s) included: SPIRONOLACTONE; OCELLA; YAZ; DEXEDRINE. Vaccination history included: BNT162B2 (DOSE 1; Lot Number: F-EP7533; 11:30 AM), administration date: 02Apr2021, when the patient was 40 years old, for COVID-19 immunization, reaction(s): "Left hand started to feel weak", "Slight pins-and-needles feeling", "Sharp pain at the bottom of her tummy". The following information was reported: MUSCULAR WEAKNESS (non-serious) with onset 26Apr2021 16:15, outcome "recovered" (28Apr2021), described as "Left hand started to feel weak"; PARAESTHESIA (non-serious) with onset 26Apr2021 16:15, outcome "recovered" (28Apr2021), described as "Slight pins-and-needles feeling"; PAIN IN EXTREMITY (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Left hand continues to hurt"; SCIATICA (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Sciatica pain in her left leg flared up"; ABDOMINAL PAIN LOWER (non-serious) with onset 27Apr2021, outcome "not recovered", described as "Sharp pain at the bottom of her tummy; lingering tummy ache"; ASTHENIA (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "General weakness"; FEELING ABNORMAL (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Brain fog"; DIZZINESS (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Dizziness"; CHILLS (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Chills"; SOMNOLENCE (non-serious) with onset 27Apr2021, outcome "recovered" (28Apr2021), described as "Slept most of the day". Therapeutic measures were not taken as a result of muscular weakness, paraesthesia, pain in extremity, sciatica, abdominal pain lower, asthenia, feeling abnormal, dizziness, chills, somnolence. Additional Information: The patient had had occasional hand weakness caused by pinched nerves in her spine in this hand (left) for two decades. The patient was not aware of any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had other unspecified medications received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 26Apr2021, the patient's left hand started to feel weak with a slight pins-and-needles feeling within a half-hour of the vaccine; much the same way but with higher intensity than after the first shot. On 27Apr2021, the left hand continues to hurt. Sciatica pain in her left leg flared up as well. Also, the patient developed a sharp pain at the bottom of her tummy. Much the same way, but with higher intensity, than following the first shot. New side-effect included general weakness, brain fog, dizziness, and chills. The patient slept most of the day. No fever. On 28Apr2021, the patient felt fine with the exception of lingering tummy ache. The patient was asking if the company would be testing a booster vaccine for the SA B.1.351 variant in the near future. If so, she would like to participate. The patient spent the majority of the pandemic to date abroad. The patient was back in her home country now, but she was planning a 3-month long trip back to the other country at the end of Jul2021. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021516202 Same patient and product; different events and dose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Pinched nerve; Weakness in extremity
Andere Medikamente
SPIRONOLACTONE; OCELLA; YAZ; DEXEDRINE
Allergien
-
Vorherige Impfungen
-

VAERS 1811381

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Fb-er8735

moderat
Staat
MA
Alter
28,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
22.04.2021
Beginn
24.04.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Malaise Migraine Rash Vomiting

Symptomtext

48 hours after vaccinestarted getting headache; Rash on hip; Terrible migraine; Throwing up; Delayed response; Felt a little sick; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Fb-er8735) via an unspecified route of administration in the left arm on 22Apr2021 at 17:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. The patient did not receive any vaccination within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: F-ep7533) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 17:00, the patient experienced delayed response, felt little sick, felt better, rash on hip and terrible migraine, throwing up and then 48 hours after vaccine started getting headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events delayed response, felt little sick, felt better, then 48 hours after vaccine started getting headache, rash on hip and terrible migraine and throwing up were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1243626

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FB-ER8735

moderat
Staat
MA
Alter
26,0
Geschlecht
F
Eingang
22.04.2021
Impfdatum
20.04.2021
Beginn
20.04.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactoid reaction Anxiety Chest discomfort Dyspnoea Throat tightness Vital signs measurement

Symptomtext

Patient received first dose of Pfizer Covid-19 Vaccine. Patient has a history of allergies to shrimp. Patient was directed to observation for a 30 minute waiting period. Patient stated that she was feeling constriction in her throat, SOB, chest tightness. Patient presented as anxious and having trouble breathing. Patient was assessed by RN, vitals were taken and recorded upon further exam, patient presented with more symptoms of anaphylaxis. ED proceed out was called. RN administered epinephrine to the L lateral thigh. ED team arrived and patient was evaluated and patient was taken to ED with ED team. In ED patient received diphenhydramine oral tablets and was observed for few hours. No further complaint was reported. Patient was discharged home afterwards.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Shrimp
Vorherige Impfungen
-

VAERS 1651064

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FB-ER8735

mild
Staat
MA
Alter
27,0
Geschlecht
M
Eingang
28.08.2021
Impfdatum
29.04.2021
Beginn
30.04.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature Chills Fatigue Pyrexia Vaccination site pain

Symptomtext

Fever up to 102.5 F; Chills; Fatigue; Intense pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FB-ER8735) via an unspecified route of administration in the left arm on 29Apr2021 at 13:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had known allergies to egg and tree nuts. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COCID vaccine. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FB-EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 09:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 01:00, the patient experienced fever up to 102.5 F (Degrees Fahrenheit), chills, fatigue and intense pain at injection site. Therapeutic measures were taken as a result of fever up to 102.5 F, chills, fatigue and intense pain at injection site and included treatment with OTC acetaminophen, ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever up to 102.5 F (Degrees Fahrenheit), chills, fatigue and intense pain at injection site were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Test Date: 20210430; Test Name: Body temperature; Result Unstructured Data: Test Result:102.5 Units:[degF]; Comments: Fever up to 102.5 F
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy to nuts (Known allergies to tree nuts); Egg allergy (Known allergies to egg)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-